This content is current only at the time of printing. This document was printed on 8 March 2021. A current copy is located at https://apvma.gov.au/node/60291
Print this page
You are here
Draft guideline on manufacturing site transfer requirements for immunobiological products
This draft document was published for consultation starting 18 December 2019, ending 28 February 2020.